HIGHLIGHTS
- who: Wiyada Wongwiwat et al. from the University of Arizona London, United Kingdom have published the research work: Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases, in the Journal: (JOURNAL) of 27/05/2022
- what: The authors characterize the EBV in 21 pediatric and adult patients who were treated in France for range of diseases that involve infection of T or NK cells. Using virus produced from type 1 or type 2 EBV genomes cloned in bacterial artificial chromosome (BAC) vectors the authors demonstrate infection of T cells . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.